Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Fmo5 | Rat | (+)-catechin | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of FMO5 mRNA | CTD | PMID:24763279 | Fmo5 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Fmo5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FMO5 mRNA | CTD | PMID:36331819 | Fmo5 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of FMO5 mRNA | CTD | PMID:22206623 | Fmo5 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Fmo5 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of FMO5 mRNA] | CTD | PMID:22206623 | Fmo5 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Fmo5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FMO5 mRNA | CTD | PMID:17942748 | Fmo5 | Rat | 17beta-estradiol | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of FMO5 mRNA | CTD | PMID:20106945 | Fmo5 | Rat | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of FMO5 mRNA | CTD | PMID:32145629 | Fmo5 | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of FMO5 mRNA | CTD | PMID:26496021 | Fmo5 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of FMO5 mRNA | CTD | PMID:29581250 | Fmo5 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | Fmo5 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:20005886 | Fmo5 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Fmo5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2 more ... | CTD | PMID:28433925 | Fmo5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Fmo5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2 more ... | CTD | PMID:17942748 more ... | Fmo5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FMO5 mRNA | CTD | PMID:32109520 and PMID:33387578 | Fmo5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FMO5 mRNA | CTD | PMID:20106945 more ... | Fmo5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Fmo5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of FMO5 mRNA | CTD | PMID:16962184 and PMID:21570461 | Fmo5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | FMO5 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of FMO5 mRNA | CTD | PMID:22298810 | Fmo5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FMO5 mRNA | CTD | PMID:18765683 and PMID:19770486 | Fmo5 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | Fmo5 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Fmo5 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 | Fmo5 | Rat | 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | Fmo5 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:19467301 | Fmo5 | Rat | 3-phenylprop-2-enal | increases expression | ISO | FMO5 (Homo sapiens) | 6480464 | cinnamaldehyde results in increased expression of FMO5 mRNA | CTD | PMID:19000754 | Fmo5 | Rat | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of FMO5 mRNA | CTD | PMID:30723492 | Fmo5 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of FMO5 mRNA | CTD | PMID:33297965 | Fmo5 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Fmo5 (Mus musculus) | 6480464 | Fenretinide results in increased expression of FMO5 mRNA | CTD | PMID:28973697 | Fmo5 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of FMO5 mRNA | CTD | PMID:28973697 | Fmo5 | Rat | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of FMO5 mRNA | CTD | PMID:31881176 | Fmo5 | Rat | aflatoxin B1 | affects expression | ISO | FMO5 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of FMO5 protein | CTD | PMID:20106945 | Fmo5 | Rat | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of FMO5 mRNA | CTD | PMID:33354967 | Fmo5 | Rat | aflatoxin B1 | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of FMO5 mRNA | CTD | PMID:27153756 | Fmo5 | Rat | aflatoxin B1 | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of FMO5 mRNA | CTD | PMID:19770486 | Fmo5 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of FMO5 mRNA | CTD | PMID:16483693 | Fmo5 | Rat | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of FMO5 mRNA | CTD | PMID:30779732 | Fmo5 | Rat | amphibole asbestos | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Asbestos and Amphibole results in decreased expression of FMO5 protein | CTD | PMID:20855422 | Fmo5 | Rat | antirheumatic drug | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of FMO5 mRNA | CTD | PMID:24449571 | Fmo5 | Rat | azathioprine | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Azathioprine results in decreased expression of FMO5 mRNA | CTD | PMID:22623647 | Fmo5 | Rat | belinostat | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | belinostat results in decreased expression of FMO5 mRNA | CTD | PMID:27188386 | Fmo5 | Rat | benzo[a]pyrene | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of FMO5 mRNA | CTD | PMID:19770486 | Fmo5 | Rat | benzo[a]pyrene | decreases methylation | ISO | FMO5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of FMO5 promoter | CTD | PMID:27901495 | Fmo5 | Rat | benzo[a]pyrene | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of FMO5 mRNA | CTD | PMID:20106945 more ... | Fmo5 | Rat | benzo[a]pyrene | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Benzo(a)pyrene co-treated with 1 more ... | CTD | PMID:17690111 | Fmo5 | Rat | benzo[b]fluoranthene | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of FMO5 mRNA | CTD | PMID:17690111 | Fmo5 | Rat | Benzo[ghi]perylene | affects expression | ISO | Fmo5 (Mus musculus) | 6480464 | 1 and 12-benzoperylene affects the expression of FMO5 mRNA | CTD | PMID:26377693 | Fmo5 | Rat | beta-naphthoflavone | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in decreased expression of FMO5 mRNA | CTD | PMID:22258563 | Fmo5 | Rat | beta-naphthoflavone | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FMO5 mRNA | CTD | PMID:18164116 | Fmo5 | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Fmo5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2 more ... | CTD | PMID:28433925 | Fmo5 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of FMO5 mRNA | CTD | PMID:26496021 | Fmo5 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of FMO5 mRNA | CTD | PMID:30903817 | Fmo5 | Rat | bisphenol A | affects expression | ISO | FMO5 (Homo sapiens) | 6480464 | bisphenol A affects the expression of FMO5 mRNA | CTD | PMID:30903817 | Fmo5 | Rat | bisphenol A | affects methylation | ISO | Fmo5 (Mus musculus) | 6480464 | bisphenol A affects the methylation of FMO5 promoter | CTD | PMID:27334623 | Fmo5 | Rat | bisphenol A | multiple interactions | ISO | Fmo5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2 more ... | CTD | PMID:28433925 | Fmo5 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of FMO5 mRNA and bisphenol A results in decreased expression of FMO5 protein | CTD | PMID:25181051 and PMID:32145629 | Fmo5 | Rat | bisphenol F | increases expression | ISO | Fmo5 (Mus musculus) | 6480464 | bisphenol F results in increased expression of FMO5 mRNA | CTD | PMID:38685157 | Fmo5 | Rat | buspirone | increases expression | EXP | | 6480464 | Buspirone results in increased expression of FMO5 mRNA | CTD | PMID:24136188 | Fmo5 | Rat | butanal | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of FMO5 mRNA | CTD | PMID:26079696 | Fmo5 | Rat | cadmium dichloride | affects expression | EXP | | 6480464 | Cadmium Chloride affects the expression of FMO5 mRNA | CTD | PMID:22110744 | Fmo5 | Rat | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of FMO5 mRNA | CTD | PMID:25993096 | Fmo5 | Rat | calcitriol | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of FMO5 mRNA | CTD | PMID:21592394 | Fmo5 | Rat | calcitriol | increases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of FMO5 mRNA | CTD | PMID:21592394 | Fmo5 | Rat | captan | increases expression | ISO | Fmo5 (Mus musculus) | 6480464 | Captan results in increased expression of FMO5 mRNA | CTD | PMID:31558096 | Fmo5 | Rat | carbon nanotube | affects expression | ISO | Fmo5 (Mus musculus) | 6480464 | Nanotubes and Carbon affects the expression of FMO5 mRNA | CTD | PMID:25620056 | Fmo5 | Rat | carbon nanotube | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | Fmo5 | Rat | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of FMO5 mRNA | CTD | PMID:24386269 | Fmo5 | Rat | copper(II) chloride | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | cupric chloride results in decreased expression of FMO5 mRNA | CTD | PMID:17211630 | Fmo5 | Rat | copper(II) sulfate | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of FMO5 mRNA | CTD | PMID:19549813 | Fmo5 | Rat | cyclosporin A | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of FMO5 mRNA | CTD | PMID:19770486 and PMID:23830897 | Fmo5 | Rat | cyclosporin A | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of FMO5 mRNA | CTD | PMID:20106945 more ... | Fmo5 | Rat | cyhalothrin | increases expression | EXP | | 6480464 | cyhalothrin results in increased expression of FMO5 mRNA | CTD | PMID:29727961 | Fmo5 | Rat | D-penicillamine | increases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Penicillamine results in increased expression of FMO5 mRNA | CTD | PMID:22843330 | Fmo5 | Rat | dibenz[a,h]anthracene | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Benzo(a)pyrene co-treated with 1 more ... | CTD | PMID:17690111 | Fmo5 | Rat | Dibutyl phosphate | affects expression | ISO | FMO5 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of FMO5 mRNA | CTD | PMID:37042841 | Fmo5 | Rat | dicrotophos | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of FMO5 mRNA | CTD | PMID:28302478 | Fmo5 | Rat | dioxygen | multiple interactions | ISO | Fmo5 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FMO5 mRNA | CTD | PMID:30529165 | Fmo5 | Rat | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of FMO5 mRNA | CTD | PMID:21551480 | Fmo5 | Rat | doxorubicin | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | Doxorubicin results in decreased expression of FMO5 mRNA | CTD | PMID:15033991 | Fmo5 | Rat | elemental selenium | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of FMO5 mRNA | CTD | PMID:19244175 | Fmo5 | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of FMO5 mRNA | CTD | PMID:29391264 | Fmo5 | Rat | entinostat | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | entinostat results in decreased expression of FMO5 mRNA | CTD | PMID:27188386 | Fmo5 | Rat | epoxiconazole | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of FMO5 mRNA | CTD | PMID:35436446 | Fmo5 | Rat | ethanol | increases expression | ISO | Fmo5 (Mus musculus) | 6480464 | Ethanol results in increased expression of FMO5 mRNA | CTD | PMID:19167417 | Fmo5 | Rat | ethanol | affects expression | ISO | Fmo5 (Mus musculus) | 6480464 | Ethanol affects the expression of FMO5 mRNA | CTD | PMID:30319688 | Fmo5 | Rat | fenofibrate | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of FMO5 mRNA | CTD | PMID:18253720 | Fmo5 | Rat | fenofibrate | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Fenofibrate results in decreased expression of FMO5 mRNA | CTD | PMID:25572481 | Fmo5 | Rat | fenthion | increases expression | ISO | Fmo5 (Mus musculus) | 6480464 | Fenthion results in increased expression of FMO5 mRNA | CTD | PMID:34813904 | Fmo5 | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of FMO5 mRNA | CTD | PMID:30307764 | Fmo5 | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of FMO5 mRNA | CTD | PMID:24793618 | Fmo5 | Rat | folic acid | multiple interactions | ISO | Fmo5 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of FMO5 mRNA] | CTD | PMID:22206623 | Fmo5 | Rat | folpet | increases expression | ISO | Fmo5 (Mus musculus) | 6480464 | folpet results in increased expression of FMO5 mRNA | CTD | PMID:31558096 | Fmo5 | Rat | fumonisin B1 | increases expression | ISO | Fmo5 (Mus musculus) | 6480464 | fumonisin B1 results in increased expression of FMO5 mRNA | CTD | PMID:16221962 | Fmo5 | Rat | gold atom | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Polyethyleneimine binds to Gold] which results in decreased expression of FMO5 mRNA | CTD | PMID:28433809 | Fmo5 | Rat | gold(0) | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Polyethyleneimine binds to Gold] which results in decreased expression of FMO5 mRNA | CTD | PMID:28433809 | Fmo5 | Rat | inulin | multiple interactions | ISO | Fmo5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of FMO5 mRNA | CTD | PMID:36331819 | Fmo5 | Rat | irinotecan | affects expression | EXP | | 6480464 | Irinotecan affects the expression of FMO5 mRNA | CTD | PMID:20097248 | Fmo5 | Rat | L-ascorbic acid | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Quercetin co-treated with Ascorbic Acid] results in decreased expression of FMO5 mRNA | CTD | PMID:17639512 | Fmo5 | Rat | lead diacetate | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | lead acetate results in decreased expression of FMO5 mRNA | CTD | PMID:25270620 | Fmo5 | Rat | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of FMO5 mRNA | CTD | PMID:24136188 | Fmo5 | Rat | lipopolysaccharide | multiple interactions | ISO | Fmo5 (Mus musculus) | 6480464 | Lipopolysaccharides inhibits the reaction [Indirubin E804 results in decreased expression of FMO5 mRNA] | CTD | PMID:23107598 | Fmo5 | Rat | lipopolysaccharide | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | Lipopolysaccharides results in decreased expression of FMO5 mRNA | CTD | PMID:23107598 | Fmo5 | Rat | manganese(II) chloride | decreases methylation | EXP | | 6480464 | manganese chloride results in decreased methylation of FMO5 gene | CTD | PMID:28801915 | Fmo5 | Rat | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of FMO5 mRNA | CTD | PMID:28801915 | Fmo5 | Rat | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of FMO5 mRNA | CTD | PMID:30467583 | Fmo5 | Rat | methotrexate | affects expression | ISO | Fmo5 (Mus musculus) | 6480464 | Methotrexate affects the expression of FMO5 mRNA | CTD | PMID:18502557 | Fmo5 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FMO5 mRNA and [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of FMO5 mRNA | CTD | PMID:18164116 and PMID:18253720 | Fmo5 | Rat | N-Nitrosopyrrolidine | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in decreased expression of FMO5 mRNA | CTD | PMID:32234424 | Fmo5 | Rat | nickel atom | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Nickel results in decreased expression of FMO5 mRNA | CTD | PMID:24768652 and PMID:25583101 | Fmo5 | Rat | nitrofen | increases expression | EXP | | 6480464 | nitrofen results in increased expression of FMO5 mRNA | CTD | PMID:33484710 | Fmo5 | Rat | O-methyleugenol | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | methyleugenol results in decreased expression of FMO5 mRNA | CTD | PMID:32234424 | Fmo5 | Rat | paracetamol | affects expression | ISO | Fmo5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of FMO5 mRNA | CTD | PMID:17562736 | Fmo5 | Rat | paracetamol | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of FMO5 mRNA | CTD | PMID:29067470 | Fmo5 | Rat | pentanal | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | pentanal results in decreased expression of FMO5 mRNA | CTD | PMID:26079696 | Fmo5 | Rat | perfluorononanoic acid | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of FMO5 mRNA | CTD | PMID:32588087 | Fmo5 | Rat | perfluorooctane-1-sulfonic acid | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of FMO5 mRNA | CTD | PMID:32588087 | Fmo5 | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | FMO5 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in increased expression of FMO5 mRNA | CTD | PMID:33772556 | Fmo5 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Fmo5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FMO5 mRNA more ... | CTD | PMID:36331819 | Fmo5 | Rat | perfluorooctanoic acid | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of FMO5 mRNA | CTD | PMID:32588087 | Fmo5 | Rat | perfluorooctanoic acid | increases expression | ISO | FMO5 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of FMO5 mRNA | CTD | PMID:33772556 | Fmo5 | Rat | phenformin | increases expression | EXP | | 6480464 | Phenformin results in increased expression of FMO5 mRNA | CTD | PMID:31324951 | Fmo5 | Rat | phenobarbital | increases expression | ISO | Fmo5 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of FMO5 mRNA and Phenobarbital results in increased expression of FMO5 protein | CTD | PMID:19270015 and PMID:28541575 | Fmo5 | Rat | phenobarbital | increases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Phenobarbital results in increased expression of FMO5 protein | CTD | PMID:28541575 | Fmo5 | Rat | phenobarbital | affects expression | ISO | Fmo5 (Mus musculus) | 6480464 | Phenobarbital affects the expression of FMO5 mRNA | CTD | PMID:23091169 | Fmo5 | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of FMO5 mRNA | CTD | PMID:16979875 | Fmo5 | Rat | phosgene | affects expression | ISO | Fmo5 (Mus musculus) | 6480464 | Phosgene affects the expression of FMO5 mRNA | CTD | PMID:16300373 | Fmo5 | Rat | pinostrobin | decreases phosphorylation | ISO | FMO5 (Homo sapiens) | 6480464 | pinostrobin results in decreased phosphorylation of FMO5 protein | CTD | PMID:37164308 | Fmo5 | Rat | pirinixic acid | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FMO5 mRNA | CTD | PMID:19710929 | Fmo5 | Rat | pirinixic acid | increases expression | ISO | Fmo5 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of FMO5 mRNA | CTD | PMID:17426115 more ... | Fmo5 | Rat | pirinixic acid | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of FMO5 mRNA | CTD | PMID:16985257 | Fmo5 | Rat | potassium dichromate | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of FMO5 mRNA | CTD | PMID:23608068 | Fmo5 | Rat | propanal | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | propionaldehyde results in decreased expression of FMO5 mRNA | CTD | PMID:26079696 | Fmo5 | Rat | propiconazole | increases expression | ISO | Fmo5 (Mus musculus) | 6480464 | propiconazole results in increased expression of FMO5 mRNA | CTD | PMID:21278054 | Fmo5 | Rat | quartz | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Quartz results in decreased expression of FMO5 mRNA | CTD | PMID:27917503 | Fmo5 | Rat | quercetin | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Quercetin co-treated with Ascorbic Acid] results in decreased expression of FMO5 mRNA | CTD | PMID:17639512 | Fmo5 | Rat | quercetin | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of FMO5 mRNA | CTD | PMID:21632981 | Fmo5 | Rat | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of FMO5 mRNA | CTD | PMID:18095365 | Fmo5 | Rat | resveratrol | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of FMO5 mRNA | CTD | PMID:23557933 | Fmo5 | Rat | riddelliine | increases expression | EXP | | 6480464 | riddelliine results in increased expression of FMO5 mRNA | CTD | PMID:18047722 | Fmo5 | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of FMO5 mRNA | CTD | PMID:28374803 | Fmo5 | Rat | selenium atom | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of FMO5 mRNA | CTD | PMID:19244175 | Fmo5 | Rat | senecionine | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | senecionine results in decreased expression of FMO5 mRNA | CTD | PMID:26100227 | Fmo5 | Rat | Senkirkine | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | senkirkine results in decreased expression of FMO5 mRNA | CTD | PMID:26100227 | Fmo5 | Rat | silicon dioxide | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of FMO5 mRNA and Silicon Dioxide results in decreased expression of FMO5 mRNA | CTD | PMID:25895662 and PMID:27917503 | Fmo5 | Rat | sodium arsenate | increases expression | ISO | Fmo5 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of FMO5 mRNA | CTD | PMID:21795629 | Fmo5 | Rat | sodium arsenite | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of FMO5 mRNA | CTD | PMID:29301061 | Fmo5 | Rat | sodium arsenite | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of FMO5 mRNA | CTD | PMID:37682722 | Fmo5 | Rat | sodium dichromate | increases expression | ISO | Fmo5 (Mus musculus) | 6480464 | sodium bichromate results in increased expression of FMO5 mRNA | CTD | PMID:31558096 | Fmo5 | Rat | tamoxifen | affects expression | ISO | Fmo5 (Mus musculus) | 6480464 | Tamoxifen affects the expression of FMO5 mRNA | CTD | PMID:20937368 | Fmo5 | Rat | Tesaglitazar | decreases expression | EXP | | 6480464 | tesaglitazar results in decreased expression of FMO5 mRNA | CTD | PMID:21515302 | Fmo5 | Rat | testosterone | increases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Testosterone results in increased expression of FMO5 mRNA | CTD | PMID:21592394 | Fmo5 | Rat | testosterone | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of FMO5 mRNA | CTD | PMID:21592394 | Fmo5 | Rat | tetrachloroethene | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | Tetrachloroethylene results in decreased expression of FMO5 mRNA | CTD | PMID:28973375 | Fmo5 | Rat | tetrachloromethane | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of FMO5 mRNA | CTD | PMID:27339419 and PMID:31919559 | Fmo5 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of FMO5 mRNA | CTD | PMID:31150632 | Fmo5 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of FMO5 mRNA | CTD | PMID:34492290 | Fmo5 | Rat | titanium dioxide | increases expression | ISO | Fmo5 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of FMO5 mRNA | CTD | PMID:35295148 | Fmo5 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of FMO5 mRNA | CTD | PMID:33387578 | Fmo5 | Rat | triphenyl phosphate | affects expression | ISO | FMO5 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of FMO5 mRNA | CTD | PMID:37042841 | Fmo5 | Rat | Triptolide | affects expression | EXP | | 6480464 | triptolide affects the expression of FMO5 protein | CTD | PMID:32519852 | Fmo5 | Rat | triptonide | increases expression | ISO | Fmo5 (Mus musculus) | 6480464 | triptonide results in increased expression of FMO5 mRNA | CTD | PMID:33045310 | Fmo5 | Rat | troglitazone | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | troglitazone results in decreased expression of FMO5 mRNA | CTD | PMID:19631733 and PMID:25572481 | Fmo5 | Rat | trovafloxacin | decreases expression | ISO | Fmo5 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of FMO5 mRNA | CTD | PMID:35537566 | Fmo5 | Rat | urethane | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Urethane results in decreased expression of FMO5 mRNA | CTD | PMID:28818685 | Fmo5 | Rat | valproic acid | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of FMO5 mRNA | CTD | PMID:29154799 | Fmo5 | Rat | vitamin E | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of FMO5 mRNA | CTD | PMID:19244175 | Fmo5 | Rat | vitamin E | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of FMO5 mRNA | CTD | PMID:19244175 | Fmo5 | Rat | zinc atom | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of FMO5 mRNA | CTD | PMID:16979875 | Fmo5 | Rat | zinc pyrithione | decreases expression | ISO | FMO5 (Homo sapiens) | 6480464 | pyrithione zinc results in decreased expression of FMO5 mRNA | CTD | PMID:21424779 | Fmo5 | Rat | zinc pyrithione | increases expression | ISO | FMO5 (Homo sapiens) | 6480464 | pyrithione zinc results in increased expression of FMO5 mRNA | CTD | PMID:21424779 | Fmo5 | Rat | zinc(0) | multiple interactions | ISO | FMO5 (Homo sapiens) | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of FMO5 mRNA | CTD | PMID:16979875 | |